Firm
Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Matthew Grady of Wolf Greenfield says AI presents an opportunity in patent practice for stronger collaboration between in-house and outside counsel
Discussion hosted by Bird & Bird partners also hears that UK courts’ desire to determine FRAND rates could see the jurisdiction penalised in a similar way to China
Sponsored
Sponsored
-
Sponsored by OLIVARESRommy Morales of OLIVARES explains the key elements to consider for submitting post-filing experimental evidence -
Sponsored by Hanol IP & LawMin Son of Hanol IP & Law considers the use of a re-filing strategy against non-use cancellation
-
Sponsored by RNA, Technology and IP AttorneysRachna Bakhru of RNA Technology and IP Attorneys examines the law surrounding the ‘right to publicity’ in relation to the Olympics
-
Sponsored by Tilleke & GibbinsKhin Myo Myo Aye of Tilleke & Gibbins describes how the extension of the TRIPS transition period for least developed countries will impact companies operating in Myanmar
-
Sponsored by Patrinos & KilimirisEvangelia Sioumala of Patrinos & Kilimiris looks at a recent judgment from the Athens Administrative Court of First Instance that compared conceptually and visually similar images
-
Sponsored by AJ ParkAJ Park explores a recent case which emphasises the importance of submitting reliable evidence in invalidation proceedings, even where proceedings are undefended
